[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-IDYA":3,"homepage-market-summary":31,"stock-news-IDYA":173},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"IDYA","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"IDEAYA Biosciences, Inc. Common Stock","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.","145","South San Francisco, CA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},37.36,38.52,38.54,37,37.81,-0.45,-1.19,563781.552197,13006,37.4213,42.68,26.049999,1039285.61115792,68,1851,{"status":32,"indices":33,"watchlist":77,"sectors":99,"benchmarks":155},"success",[34,42,49,56,63,70],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":40,"sparkline":41,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":43,"name":44,"price":45,"change":46,"pct_change":47,"is_up":40,"sparkline":48,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":50,"name":51,"price":52,"change":53,"pct_change":54,"is_up":40,"sparkline":55,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":57,"name":58,"price":59,"change":60,"pct_change":61,"is_up":40,"sparkline":62,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":64,"name":65,"price":66,"change":67,"pct_change":68,"is_up":40,"sparkline":69,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":71,"name":72,"price":73,"change":74,"pct_change":75,"is_up":14,"sparkline":76,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[78,85,92],{"symbol":79,"name":80,"price":81,"change":82,"pct_change":83,"is_up":40,"sparkline":84,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":86,"name":87,"price":88,"change":89,"pct_change":90,"is_up":40,"sparkline":91,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":93,"name":94,"price":95,"change":96,"pct_change":97,"is_up":40,"sparkline":98,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[100,105,110,115,120,125,130,135,140,145,150],{"name":101,"etf":102,"change":103,"price":104,"is_up":40},"Technology","XLK",1.01,199.81,{"name":106,"etf":107,"change":108,"price":109,"is_up":40},"Financials","XLF",0.06,53.49,{"name":111,"etf":112,"change":113,"price":114,"is_up":14},"Healthcare","XLV",-0.01,166.18,{"name":116,"etf":117,"change":118,"price":119,"is_up":40},"Consumer Cycl","XLY",1.13,110.04,{"name":121,"etf":122,"change":123,"price":124,"is_up":40},"Consumer Staples","XLP",0.25,80.53,{"name":126,"etf":127,"change":128,"price":129,"is_up":40},"Energy","XLE",0.4,62.95,{"name":131,"etf":132,"change":133,"price":134,"is_up":40},"Industrials","XLI",0.78,169.95,{"name":136,"etf":137,"change":138,"price":139,"is_up":40},"Materials","XLB",0.66,48.86,{"name":141,"etf":142,"change":143,"price":144,"is_up":40},"Real Estate","XLRE",0.32,40.81,{"name":146,"etf":147,"change":148,"price":149,"is_up":40},"Utilities","XLU",0.38,39.83,{"name":151,"etf":152,"change":153,"price":154,"is_up":40},"Comm Services","XLC",0.35,110.32,[156,161,165,169],{"ticker":157,"name":158,"price":159,"change":160,"is_up":40},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":162,"name":163,"price":164,"change":90,"is_up":40},"QQQ","Invesco QQQ Trust",749.58,{"ticker":166,"name":167,"price":168,"change":54,"is_up":40},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":170,"name":171,"price":172,"change":68,"is_up":40},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":174,"articles":175},8,[176,182,188,194,200,206,212,217],{"title":177,"link":178,"pubDate":179,"description":180,"source":181},"IDEAYA Biosciences (IDYA) Stock Looks Priced At A Premium Despite R And D Promotion - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Thu, 01 Oct 2026 02:19:44 GMT","IDEAYA Biosciences (IDYA) Stock Looks Priced At A Premium Despite R And D Promotion Simply Wall Street","Simply Wall Street",{"title":183,"link":184,"pubDate":185,"description":186,"source":187},"After five years as IDEAYA's chief scientist, Michael White becomes president of research and development. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivAFBVV95cUxOQURaWlpMR3Q0U1dwdWIzVTltWnlnaFFiejI1S3VqLVdvZmRXLUlVcHBtLUNHOXVuNnB3YmRZUC1ieW94SU1MYWYyWUl2OUp1NGxWVmwwYktsdnpzZjFCTTNxOU5xZGpBR3VYX0xwaFV2M1B3MW9FV2duYUI1YlBISFJYSHdhSHc2S1Q1QmRxMHI2aUt5US1sNGQ4NFdLZHBxS1hRaFllLTFSS0NCNG53LXlZN2JTUk9mWkpuRg?oc=5","Mon, 28 Sep 2026 10:00:00 GMT","After five years as IDEAYA's chief scientist, Michael White becomes president of research and development. Stock Titan","Stock Titan",{"title":189,"link":190,"pubDate":191,"description":192,"source":193},"Can IDEAYA Biosciences (IDYA) Turn Uncharted Oncology Territory Into Commercial Gold? - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMioAFBVV95cUxORnNjeTRJYUZiNTh3M0ctNTRsZDBqTzNNRU51dFlnN08zaTl5M0xMVjU5MEQ1VkE2WjliS2R6OUY3Zmt1aXpPV3k3MmlIbWN1bGJIdmdoOU15Y3QxT25wNWFWOF9HZWIycFFueDNYSDVtR2RnQW1WcVJPNWhQblc2Z2VSVV8wdjBqdzJQNEdnbGgxb1RrWnVWQVNLaWtPTE90?oc=5","Fri, 25 Sep 2026 07:00:00 GMT","Can IDEAYA Biosciences (IDYA) Turn Uncharted Oncology Territory Into Commercial Gold? Yahoo Finance","Yahoo Finance",{"title":195,"link":196,"pubDate":197,"description":198,"source":199},"Discipline and Rules-Based Execution in IDYA Response - Stock Traders Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMizgFBVV95cUxOd2xKYXVtTFdUSVhZbUZHY0dsc0FaUkFfc2xmN2FxQTFHZTZWdU9kQmtIOG5fOTk5dlJXRVFQOWtVUUlXMkVpallWVFNxSkJxb09nS3dNU1RSNUx6YnVLMW1DdVlXTU85QlA4QzZYSFlVcDBZcVpxMGdWczZvb1JOWHZJT0cwNUJldVRMMzZOT2hEVEJRQzE1NnB0MXFwUUd2MjNXM0JORllmRjQ2TmhZbVJQSklWeHJvbTdTTkhKREJJbVEtT3Iwd2pJZW45UQ?oc=5","Fri, 02 Oct 2026 06:12:01 GMT","Discipline and Rules-Based Execution in IDYA Response Stock Traders Daily","Stock Traders Daily",{"title":201,"link":202,"pubDate":203,"description":204,"source":205},"IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Santa Maria Times","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Fri, 25 Sep 2026 10:00:00 GMT","IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Santa Maria Times","Santa Maria Times",{"title":207,"link":208,"pubDate":209,"description":210,"source":211},"Cantor Fitzgerald reiterates Ideaya Biosciences stock rating By Investing.com - Investing.com India","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivgFBVV95cUxNUlZfdVl6bU5PZjJyNFhBR2pFS3JtbC1namhGQlFrUm5lQ1F3a05BeTFtTlpEWUJhc0lRVlV1LXhjRHVJZ2UyQ251aU9XR3F0S2N2a2J0OGNkTnRfaU9aQWdVVXF6S2c5N19rWTFyWWhWTWVWQ1ppWlFzajZnUDhlWnROb0xsclNoRklic1lYWlg3cGdtTWlBbWNrNWlFVWozNnRVdm8tXzh2Znc4VG0zUTNuQWd5SkQ2T3k3NVZ3?oc=5","Tue, 22 Sep 2026 13:10:17 GMT","Cantor Fitzgerald reiterates Ideaya Biosciences stock rating By Investing.com Investing.com India","Investing.com India",{"title":213,"link":214,"pubDate":215,"description":216,"source":181},"IDEAYA Biosciences (IDYA) Could Be 41% Undervalued On Leadership Change - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi5wFBVV95cUxNcU50c3pQSzRCTjRQdGxtbE5EVXlyaGQ1dEpBRE1BaWh1SXJhajF4VXZadWZEVXVoV21NajkwY3I4UXJteXh4SlIycmpVWEhBTGt6VWVhbFJKd0tFNlZNQ1c2LTRuTjlleTFGaFlhLWRrbkxTSnlDVlFvcHVzbFZ6WXB0UFNUYkpTRS0xWmQ0d1hqSm1kYWdhUjJlY3pHTHVBaExqeWZYVmYzVjZzYXNsMU9JcEs2VFREU1l3M2NwVGdLaC1veVlUellOVnF0dmdfY0pubzA4SFdRODFOYTA1NnlaYS1pWWvSAewBQVVfeXFMTUdQTGk1TE0tTXdVYzFmbWpFc25BYm1qaHQ3b0NMQkFvaWxTQlpVWlNjWnowdjRpREZ1ekNsU2hxaEVxT1dWNml5QWdaV1F2ZVdQd2JhOG40VjdQVHVUOXRGb2pTdmttWXFld1RQZmhLTHRXc3ZXZmd5Vm5jUDZ2dUpWT0pYVXpNazlkNVV5NXlSenhyZjZ0eUU0bl9vY2FjYVcxTXpqSUFNcUxoVU5ob0xZY2R2TVFYLUNpaFByMlRTaWc1Y1lEQnhRdlBKOFprZ19xaV9CZERJU01LMWsyZzFvM05mVXRSQ3pPVnk?oc=5","Tue, 29 Sep 2026 14:32:32 GMT","IDEAYA Biosciences (IDYA) Could Be 41% Undervalued On Leadership Change Simply Wall Street",{"title":218,"link":219,"pubDate":220,"description":221,"source":222},"IDEAYA Biosciences stock reports Q2 revenue growth despite loss - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivwFBVV95cUxNTUtYUDJRRW1lNVNlRVpYRG1Db085YUFvYm9wYkFGSGtPWlhqbEZPUmF1WGVqOU5Ra2x2SXZOZ3pRaHFUU3JiemhQVk9RR2tyNkt2OS1YMFFwVk9ia0tyYlJvazVJSGpCQWcxN2tJTF8zSjBvYzBBOHFMd0hxYXF0Q2hWX3JvSjFRSGRBcF9fdHpGaDM3QUtNSFRtMkRRejRiUWY1Q0dyWUtxRkhvLVpLalNta29TeVVlMnJLdDFlYw?oc=5","Thu, 01 Oct 2026 00:22:09 GMT","IDEAYA Biosciences stock reports Q2 revenue growth despite loss AD HOC NEWS","AD HOC NEWS"]